Trials / Completed
CompletedNCT03049657
Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention
Randomized Clinical Trial to Compare the Efficacy of Angiolite Stent Versus a Second-generation Drug-eluting Stent Such as Xience in Patients With Indication of Percutaneous Coronary Intervention
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 220 (actual)
- Sponsor
- Cardiva2 S.L. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Clinical trial with an "European Community marked" medical device in patients with ischemic heart disease and clinical indication of coronary revascularization with drug-eluting stent. Clinical follow-up will be done according to this way: first month telephone or face-to-face interview and at 6 ± 1 month an Angiography follow up + OCT (optical coherence tomography) A randomized clinical trial to compare the efficacy of Angiolite Stent versus a second-generation drug-eluting stent such as Xience stent.(non-inferiority design)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Angiolite | Percutaneous coronary intervention |
| DEVICE | Xience | Percutaneous coronary intervention |
Timeline
- Start date
- 2016-02-02
- Primary completion
- 2017-03-31
- Completion
- 2019-01-28
- First posted
- 2017-02-10
- Last updated
- 2019-04-12
Locations
11 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT03049657. Inclusion in this directory is not an endorsement.